At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

The U.S. Centers for Disease Control's vaccine advisory committee voted to recommend the single-dose vaccine, Vimkunya, for the prevention chikungunya in 12 years and older traveling to a country ...

For meningococcal vaccines, ACIP recommended that GSK's pentavalent vaccine (Penmenvy), designed to protect against A, B, C, ...

Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or elevated risk of chikungunya. COPENHAGEN, Denmark, ...

VIMKUNYA was approved by the U.S. Food and Drug Administration (FDA) and the European Commission in February 2025 6,7.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

A two-day meeting of the Advisory Committee on Immunization Practices (ACIP), which was originally scheduled for February but ...

Kenya will soon launch its first Mpox vaccination campaign in 13 counties to prevent transmission of the virus.This follows the arrival of 10,700 doses of the Modified Vaccinia Ankara-Bavarian Nordic ...

In response to a sharp rise in Mpox infections, the Ministry of Health has announced the arrival of 10,700 doses ...

In a statement on Thursday, April 10, the Health Cabinet Secretary, Aden Duale, confirmed that the country has received ...

Nairobi — Health Cabinet Secretary Aden Duale has called on Kenyans to remain vigilant and strictly adhere to public health ...